Report cover image

Sexually Transmitted Disease Diagnostics Market by Disease Type (Bacterial Vaginosis, Candidal Vaginitis, Chlamydia Trachomatis/ Neisseria Gonorrhoeae), Diagnostic methods (Antigen Detection, Molecular Diagnostics, Serologic Testing), Device Type, End-Use

Publisher 360iResearch
Published Apr 17, 2024
Length 180 Pages
SKU # IRE18713689

Description

Sexually Transmitted Disease Diagnostics Market by Disease Type (Bacterial Vaginosis, Candidal Vaginitis, Chlamydia Trachomatis/ Neisseria Gonorrhoeae), Diagnostic methods (Antigen Detection, Molecular Diagnostics, Serologic Testing), Device Type, End-Users - Global Forecast 2024-2030


The Sexually Transmitted Disease Diagnostics Market size was estimated at USD 106.53 billion in 2023 and expected to reach USD 112.56 billion in 2024, at a CAGR 5.97% to reach USD 159.97 billion by 2030.

Sexually transmitted disease diagnostics refers to the range of medical tests, physical examinations, and procedures used to identify infections transmitted through sexual contact. These diagnostics are crucial for the early detection, treatment, and prevention of sexually transmitted diseases, supporting public health efforts and individual well-being. The methodologies for Sexually transmitted disease (STD) diagnostics vary, including laboratory-based tests such as nucleic acid amplification tests, cultures, enzyme immunoassays (EIAs), and point-of-care tests that offer rapid results. The rising prevalence of STDs worldwide is a major contributor to the growth of diagnostics. This increase is attributed to changing sexual behaviors, lack of education and awareness regarding sexual health, and insufficient screening programs in certain regions. The need for effective diagnostic solutions is thus highlighted, prompting an uptick in demand for STD diagnostics. However, the social stigma associated with STDs remains a significant challenge for STD diagnostic providers. Companies are increasingly focusing on STD prevention and control as part of their public health initiatives. Moreover, the rapid progress in medical diagnostic technologies, including molecular diagnostics, Polymerase Chain Reaction (PCR) testing, and immunoassays, has significantly enhanced the accuracy, efficiency, and speed of STD testing. These technological advancements facilitate the early detection and treatment of STDs, further driving the growth of STD diagnostics.



Please Note: PDF & Excel + Online Access - 1 Year

Table of Contents

180 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. The rising prevalence of sexual diseases worldwide and the need for effective diagnostic solutions
5.1.1.2. Increasing implementation of worldwide screening to reduce the stigma associated with STD
5.1.2. Restraints
5.1.2.1. Lack of adequate awareness and education about STDs
5.1.3. Opportunities
5.1.3.1. Increased funding and public health campaigns for STD awareness and prevention
5.1.3.2. Innovations in next-generation sequencing and CRISPR-based diagnostics
5.1.4. Challenges
5.1.4.1. Stringent government regulations for drug approvals and complications arising from untreated infections
5.2. Market Segmentation Analysis
5.2.1. Disease Type: Advancements in next-generation sequencing and CRISPR-based diagnostics to cater varied STDs
5.2.2. End-Users: Increasing adoption of STD diagnostics in clinical and hospital settings to cater complicated STD cases
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Sexually Transmitted Disease Diagnostics Market, by Disease Type
6.1. Introduction
6.2. Bacterial Vaginosis
6.3. Candidal Vaginitis
6.4. Chlamydia Trachomatis/ Neisseria Gonorrhoeae
6.5. Genital Warts
6.6. Hepatitis B
6.7. HIV/AIDS
6.8. Mycoplasma Genitalium
6.9. Syphilis
6.10. Trichomoniasis
7. Sexually Transmitted Disease Diagnostics Market, by Diagnostic methods
7.1. Introduction
7.2. Antigen Detection
7.3. Molecular Diagnostics
7.4. Serologic Testing
8. Sexually Transmitted Disease Diagnostics Market, by Device Type
8.1. Introduction
8.2. Laboratory Devices
8.3. Point of Care Devices
9. Sexually Transmitted Disease Diagnostics Market, by End-Users
9.1. Introduction
9.2. Clinics
9.3. Diagnostic Laboratories
9.4. Hospitals
9.5. Public Health Agencies
9.6. Research Institutions
10. Americas Sexually Transmitted Disease Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Sexually Transmitted Disease Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Sexually Transmitted Disease Diagnostics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. British startup launches tampon that offers STI screening
13.3.2. BioPerfectus Launches New PCR Kits for Sexually Transmitted Diseases Diagnostic Solution
13.3.3. Mylab Launches rapid tests for sexually transmitted diseases
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
FIGURE 1. SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHODS, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 14. GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us